Drug Topics February 1, 2025
Brian Nowosielski

In their exploration of 2 separate respiratory virus seasons, researchers examined the severity of illness for SARS-CoV-2, influenza, and respiratory syncytial virus.

During the 2022-23 respiratory virus season, patients infected with SARS-CoV-2 experienced significantly worse disease outcomes when compared with influenza and respiratory syncytial virus (RSV). While these differences were less prominent in the following season, RSV remained significantly mild and COVID-19 had increased long-term mortality outcomes throughout both seasons, according to data published in JAMA Internal Medicine.1

“Respiratory viral illnesses caused by SARS-CoV-2, influenza, and RSV are associated with substantial morbidity and mortality in older adults and persons with chronic medical conditions,” wrote authors of the study. “In the US, influenza and COVID-19 vaccinations are recommended for all adults,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
25K hospital units show post-pandemic safety gains: 5 notes
Almost 7 in 10 concerned about measles outbreak: Poll
White House pulls CDC director pick; HHS office consolidates — 9 updates
How Health Plans Can Support Communities During Natural Disasters
Europeans Have Lost Millions of Years of Life to COVID

Share This Article